World's Best Scientists 2026 revealed!
Award Badge
Immunology
Greece
2023

D-Index & Metrics

Immunology

D-Index
96
Citations
43731
World Ranking
844
National Ranking
4

Medicine

D-Index
98
Citations
45298
World Ranking
8800
National Ranking
23

Research.com Recognitions

  • 2023 - Research.com Immunology in Greece Leader Award
  • 2022 - Research.com Immunology in Greece Leader Award
  • 2018 - Member of Academia Europaea

Overview

Dimitrios T. Boumpas is affiliated with the National and Kapodistrian University of Athens in Greece. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with notable contributions to the subfields of Rheumatology, Immunology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, and Oncology.

The scientist has a significant focus on systemic autoimmune and inflammatory diseases, reflected in their main topics of work, which include:

  • Systemic Lupus Erythematosus Research
  • Rheumatoid Arthritis Research and Therapies
  • Atherosclerosis and Cardiovascular Diseases
  • T-cell and B-cell Immunology
  • Monoclonal and Polyclonal Antibodies Research
  • Renal Diseases and Glomerulopathies
  • Spondyloarthritis Studies and Treatments

Among recent papers associated with Dimitrios T. Boumpas, the following are notable for their contributions and publication in key venues:

  • 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis, 2020, Annals of the Rheumatic Diseases
  • EULAR recommendations for the management of systemic lupus erythematosus: 2023 update, 2023, Annals of the Rheumatic Diseases
  • Update on the diagnosis and management of systemic lupus erythematosus, 2020, Annals of the Rheumatic Diseases
  • EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome, 2022, Annals of the Rheumatic Diseases
  • 2021 DORIS definition of remission in SLE: final recommendations from an international task force, 2021, Lupus Science & Medicine

The frequent co-authors collaborating with Dimitrios T. Boumpas include:

  • George Βertsias
  • Antonis Fanouriakis
  • Dionysis Nikolopoulos
  • Prodromos Sidiropoulos
  • Aggelos Banos

Publication venues where this scientist has contributed extensively cover:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Poster presentations
  • RMD Open
  • Mediterranean Journal of Rheumatology

Dimitrios T. Boumpas also holds a book publication with IntechOpen titled Systemic Lupus Erythematosus - Pathogenesis and Management published in 2022.

The scientist was honored as a Member of Academia Europaea in 2018.

Best Publications

  • 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

    Martin Aringer;Karen Costenbader;David Daikh;Ralph Brinks

  • Treating rheumatoid arthritis to target: recommendations of an international task force

    Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld

  • 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Antonis Fanouriakis;Myrto Kostopoulou;Alessia Alunno;Martin Aringer

  • Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

    George K Bertsias;Maria Tektonidou;Zahir Amoura;Martin Aringer

  • Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates

    Dimitrios T. Boumpas;George P. Chrousos;Ronald L. Wilder;Thomas R. Cupps

  • Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

    D.T. Boumpas;H.A. Austin;J.E. Balow;E.M. Vaughan

  • EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

    G. Bertsias;J. P. A. Ioannidis;J. Boletis;S. Bombardieri

  • EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome

    L. Andreoli;G. K. Bertsias;N. Agmon-Levin;S. Brown

  • EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    G K Bertsias;J P A Ioannidis;M Aringer;E Bollen

  • Treat-to-target in systemic lupus erythematosus: recommendations from an international task force

    Ronald van Vollenhoven;Marta Mosca;George Bertsias;David Isenberg

  • 2019 Update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis

    Antonis Fanouriakis;Myrto Kostopoulou;Kim Cheema;Hans Joachim Anders

  • Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis : A randomized, controlled trial

    Mark F. Gourley;Howard A. Austin;Dorothy Scott;Cheryl H. Yarboro

  • A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.

    Dimitrios T. Boumpas;Richard Furie;Susan Manzi;Gabor G. Illei

  • Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

    K Visser;W Katchamart;E Loza;J A Martinez-Lopez

  • Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

    Gabor G. Illei;Howard A. Austin;Marianna Crane;Lee Collins

  • Update οn the diagnosis and management of systemic lupus erythematosus

    Antonis Fanouriakis;Nikolaos Tziolos;George Bertsias;Dimitrios T Boumpas

  • Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide Therapy

    Dimitrios T. Boumpas;Howard A. Austin;Ellen M. Vaughan;Cheryl H. Yarboro

  • European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

    L Gossec;J S Smolen;C Gaujoux-Viala;Z Ash

  • EULAR evidence based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

    J. N. Hoes;J. W. G. Jacobs;M. Boers;D. Boumpas

  • Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data

    Howard A. Austin;Dimitrios T. Boumpas;Ellen M. Vaughan;James E. Balow

  • Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis

    Mark F. Gourley;Howard A. Austin;Dorothy Scott;Cheryl H. Yarboro

Frequent Co-Authors

James E. Balow
James E. Balow National Institutes of Health
Alexandros A. Drosos
Alexandros A. Drosos University of Ioannina
Martin Aringer
Martin Aringer TU Dresden
Josef S. Smolen
Josef S. Smolen Medical University of Vienna
Marta Mosca
Marta Mosca University of Pisa
Andrea Doria
Andrea Doria University of Padua
Gabor G. Illei
Gabor G. Illei Horizon Therapeutics
David Jayne
David Jayne University of Cambridge
Ricard Cervera
Ricard Cervera University of Barcelona
George C. Tsokos
George C. Tsokos Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, expanding your qualifications with nursing degrees can open diverse career pathways. Many professionals pursue the cheapest psych np programs online to specialize in psychiatric care, combining immune system knowledge with mental health expertise.

Understanding salary potentials is also crucial when planning your career. The dnp salary varies by state and specialty, offering insight into the financial benefits of becoming a Doctor of Nursing Practice in immunology-related fields.

If you are a Family Nurse Practitioner (FNP) considering further specialization, resources on how to fnp to acnp transitions provide guidance on moving into acute care settings, which often involve advanced immunology knowledge.

Accelerated degree options can fast-track your education. Exploring the accelerated nurse practitioner program listings helps prospective students find the best fit for quickly entering immunology-focused nursing roles.

Best Scientists Citing Dimitrios T. Boumpas

Trending Scientists